Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2021-05-28 Annual Report
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
国金证券关于无锡祥生医疗科技股份有限公司2020年年度报告的信息披露监管问询函的专项核查意见
Annual Report Classification · 95% confidence The document is a detailed regulatory inquiry response and special inspection opinion from Guojin Securities Co., Ltd. regarding the 2020 Annual Report of Wuxi Xiangsheng Medical Technology Co., Ltd. It contains extensive financial data, operational analysis, risk disclosures, and management explanations related to the company's 2020 fiscal year. The content includes revenue breakdowns, sales analysis, inventory details, employee and R&D personnel changes, and risk factors, all typical of a comprehensive annual report. The document is lengthy (15,000 characters) and contains substantive financial and operational information rather than just an announcement or a brief summary. Therefore, it fits the definition of an Annual Report (10-K). FY 2020
2021-05-28 Chinese
祥生医疗关于对上海证券交易所2020年年度报告问询函的回复公告
Annual Report Classification · 95% confidence The document is a detailed reply to an inquiry letter from the Shanghai Stock Exchange regarding the company's 2020 Annual Report. It contains extensive financial data, operational analysis, risk disclosures, and management explanations related to the 2020 fiscal year. The content includes revenue breakdowns, sales policies, inventory details, employee statistics, and R&D activities, all tied to the 2020 Annual Report. The document is lengthy (15,000 characters) and contains substantive financial and operational information, not merely an announcement or certification. Therefore, it is the actual Annual Report or a detailed part of it, not just an announcement or a regulatory filing. The presence of detailed financial figures, management discussion, and audit-related confirmations aligns with the definition of an Annual Report (10-K). FY 2020
2021-05-28 Chinese
容诚会计师事务所（特殊普通合伙）关于对无锡祥生医疗科技股份有限公司2020年年度报告的信息披露监管问询函的回复
Audit Report / Information Classification · 95% confidence The document is a detailed response from an accounting firm (容诚会计师事务所) to a regulatory inquiry by the Shanghai Stock Exchange's Sci-Tech Innovation Board regarding the 2020 annual report of Wuxi Xiangsheng Medical Technology Co., Ltd. It includes audit opinions, detailed explanations about inventory increases, inventory impairment provisions, inventory aging, and the audit procedures performed. The document references the 2020 annual report and provides an audit report number with a standard unqualified opinion. The content is technical and focused on audit and accounting matters related to the annual report but is not the annual report itself. It is a standalone audit-related report responding to a regulatory inquiry about the annual report disclosures. Therefore, it fits the definition of an Audit Report / Information (AR) rather than the full Annual Report (10-K) or a simple announcement. The document length (5147 characters) and detailed audit content support this classification with high confidence. FY 2020
2021-05-28 Chinese
祥生医疗关于全资子公司开立募集资金专项账户并签订募集资金专户存储三方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the opening of a special account for raised funds by a wholly-owned subsidiary and the signing of a tripartite supervision agreement related to the management and use of these funds. It details the background of the fundraising, the establishment of the special account, and the terms of the supervision agreement. There are no financial statements, quarterly or annual results, or detailed financial performance data included. The document is relatively short (3274 characters) and serves as a formal announcement about the management of fundraising proceeds rather than a financial report or audit. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2021-05-24 Chinese
祥生医疗关于公司核心技术人员离职的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the departure of a core technical staff member from the company, detailing the individual's role, confidentiality and non-compete agreements, impact on ongoing projects, and company measures to mitigate any negative effects. It includes no financial data, no regulatory filings, no voting results, no capital changes, and no report publication statements. The content focuses on management-level personnel changes specifically related to a key technical employee. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management or key personnel.
2021-05-19 Chinese
国金证券股份有限公司关于无锡祥生医疗科技股份有限公司核心技术人员离职的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from a sponsoring institution (Guojin Securities Co., Ltd.) regarding the departure of a core technical staff member from Wuxi Xiangsheng Medical Technology Co., Ltd. It includes information about the individual's role, confidentiality and non-compete agreements, impact on R&D projects, and the company's measures to mitigate the impact. The document is a formal verification or due diligence report related to personnel changes, not a financial report, earnings release, or regulatory filing about financial results. It is not an announcement of voting results, nor a management or board change announcement. It is a specialized verification opinion related to a personnel matter in the context of an IPO or listing process. This type of document fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure that does not fit other specific categories like MANG (management changes) or MDA (management discussion). The document length is 3430 characters, which is relatively short and focused on a specific verification topic, supporting the RNS classification rather than a full report type.
2021-05-19 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.